These studies suggest that RUNX2 is a target gene in ovarian cancer, which is in accordance with previous studies that demonstratedmiR-218 targets RUNX2 in non-small cell lung cancer [22] and human dental stem cells [23]. This evidence concerns the gene RUNX2 and ovarian carcinoma.